Who is sponsoring NCT05151367?

NCT05151367 is sponsored by Columbia University.

What drugs are being tested in NCT05151367?

Interventions in NCT05151367: Text message reminder.

What condition does NCT05151367 study?

NCT05151367 studies Human Papillomavirus Vaccination.

Is NCT05151367 still recruiting?

NCT05151367 is currently completed. Last updated 8 July 2024.

Are results published for NCT05151367?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2024-07-08 · How we verify

NCT05151367: SEARCH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SMS HPV Vaccine Reminders

Completed NA Results posted Last updated 8 July 2024

What this trial tests

NA trial testing Text message reminder in Human Papillomavirus Vaccination in 154 participants. Completed in 31 December 2022.

Timeline

23 February 2022

Primary endpoint
30 October 2022

31 December 2022

Quick facts

Lead sponsor	Columbia University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	health services research
Enrollment	154
Start date	23 February 2022
Primary completion	30 October 2022
Estimated completion	31 December 2022
Sites	2 locations across United States, Uganda

Drugs / interventions tested

Text message reminder

Conditions studied

Human Papillomavirus Vaccination — all drugs for Human Papillomavirus Vaccination →

Sponsor

Columbia University

Who can join

Adults 10 to 14, female only, with Human Papillomavirus Vaccination. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Participants Who Received the Next HPV Vaccine Dose Primary · Up to 6 months from randomization

Timeliness of vaccination will be measured by the number of participants who received the next HPV vaccine dose.

Group	Value	95% CI
Text Message Reminders	51
Usual Care	27

Sponsor's own description

This study will take place at health centres and their affiliated schools and community immunization centers overseen by the Kampala Capital City Authority (KCCA) as well as at the Makerere/Mulago/Columbia Adolescent Health Clinic, also in Kampala. While text messages can be used in populations with low literacy, families can opt to receive automated phone call reminders instead. The investigators will pilot assess the impact of vaccine reminders on human papillomavirus (HPV) vaccination. Caregivers of preteens/adolescents will be randomized and stratified by site, language and HPV vaccine dose needed (initiation vs. completion). As this is a feasibility trial, the investigators expect to measure effect size but not necessarily achieve statistical significance.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

SEARCH Study: Text Messages and Automated Phone Reminders for HPV Vaccination in Uganda: Randomized Controlled Trial.
Kitaka SB, Rujumba J, Zalwango SK, Pfeffer B, et al · · 2025 · cited 4× · PMID 40324213 · DOI 10.2196/63527

Verify or expand the search:

Other trials of Text message reminder

Trials testing the same drug.

NCT06587984 — Influenza Reminder Text-Messaging · NA · completed
NCT03013192 — Three Month Automated Messaging Intervention · NA · terminated

Other recruiting trials for Human Papillomavirus Vaccination

Currently open trials in the same condition.

NCT06808776 — Stories to Prevent (StoP) HPV Cancers · NA · recruiting
NCT06161831 — HPV Vaccine Reminders - SEARCH II Study · NA · active not recruiting

Other Columbia University trials

Trials by the same sponsor.

NCT06558422 — Human Models of Selective Insulin Resistance: Pancreatic Clamp · Phase 1 · not yet recruiting
NCT07264582 — HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking · NA · not yet recruiting
NCT05992415 — Know Your Pressures NYC · NA · not yet recruiting
NCT05645211 — The AgRP and GH/IGF-1 Axis in Children · not yet recruiting
NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05151367 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Columbia University
Last refreshed: 8 July 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05151367.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing